BCLI

BRAINSTORM CELL THERAPUTC
BCLI

Overview Fund Activity
Delisted

BCLI was delisted on the 17th of July, 2025.

Back to rankings

23 hedge funds and large institutions have $3.93M invested in BRAINSTORM CELL THERAPUTC in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 9 closing their positions.

Holders
23
Holders Change
-5
Holders Change %
-17.86%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
4
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Bank of America
1
Bank of America
North Carolina
$24K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.19M
3
UBS Group
3
UBS Group
Switzerland
$13K
4
AG
4
Advisor Group
Arizona
$3K

Top Sellers

1
ARTA
1
A.R.T. Advisors
New York
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$0
3
SM
3
Sabby Management
Florida
$1.15M
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
LPL Financial
5
LPL Financial
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
LPL Financial
26
LPL Financial
California
– – -10,000 Closed
PCM
27
Penserra Capital Management
California
– – -4,980 Closed
Bank of Montreal
28
Bank of Montreal
Ontario, Canada
– – -1,000 Closed
TRCT
29
Tower Research Capital (TRC)
New York
– – -999 Closed
DOA
30
D'Orazio & Associates
Virginia
– – -500 Closed
AIG
31
American International Group
New York
– – -500 Closed
DE
32
Day & Ennis
Georgia
$0 4 +4 New
1
2